Low Cervical Cancer Screening Rates Found Among Mentally Ill
Women enrolled in California’s Medicaid program (Medi-Cal) who have been diagnosed with severe mental illness have been screened for cervical cancer at much lower rates than other women.
University of California San Francisco
Give to UCSF
Quest for Balance in Radiation Leads to Lower Doses
A new study led by UC San Francisco has found that radiation doses can be safely and effectively reduced – and more consistently administered – for common CT scans.
New Tool Illuminates Cell Signaling Pathways Key to Disease
In a major advance for fundamental biological research, UCSF scientists have developed a tool capable of illuminating previously inscrutable cellular signaling networks.
Cognitive Decline After Surgery Tied to Brain’s Own Immune Cells
After undergoing surgery, elderly patients often experience cloudy thinking. Mounting evidence suggests that heightened inflammation in the brain following surgery is the more likely cause.
Video Game Promotes Better Attention Skills in Some Children with Sensory Processing Dysfunction
A video game under development as a medical device boosts attention in some children with sensory processing dysfunction.
How Computers are Searching for Drugs of the Future
Researchers at UCSF and elsewhere are turning to virtual experiments for the initial steps of drug development.
Race Ranks Higher than Pounds in Diabetes, Heart-Health Risks
Americans of South Asian descent are twice as likely as whites to have risks for heart disease, stroke and diabetes, when their weight is in the normal range.
Parental Smoking Linked to Genetic Changes Found in Childhood Cancer
Smoking by either parent helps promote genetic deletions in children that are associated with the development and progression of the most common type of childhood cancer, according to research headed by UCSF.
Deworming Pill May Be Effective in Treating Liver Cancer
UCSF researchers have used data-mining computational tools to identify a treatment for hepatocellular carcinoma, a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced.
New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis is holding new hope for the hundreds of thousands Americans living with the disease. It also highlights the importance of clinician scientists like UCSF’s Stephen Hauser who are working to transform research into cures for patients.
Virtual System Works in Managing Diabetes for Hospital Patients
An innovative virtual glucose management service for hospitalized patients with diabetes is highly effective at maintaining appropriate glucose levels.
New Polio Virus Evolution Insights Could Lead to Improved Vaccine
UCSF researchers have helped to identify the three evolutionary steps the polio virus used to evolve from harmless vaccine into a regional menace. With the new knowledge, they have developed a new polio vaccine that should be unable to escape and cause outbreaks.
UCSF Is Top Public Recipient of NIH Research Funding for 10th Consecutive Year
UCSF was the top public recipient of biomedical research grants from the National Institutes of Health or the sixth consecutive year in 2016, and the second-highest recipient among all public and private institutions nationwide.
2016 NIH Funding: A Look at Top Recipients and Their Research
Learn more about some of the UCSF researchers who received the top funding from the National Institutes of Health in 2016.
